Home lactate and Accu‑Chek glucose meter accuracy for people with glycogen storage disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational protocol enrolls patients with genetically or biopsy-confirmed Glycogen Storage Disease Types Ia, Ib, or XI for a one-time, planned admission at Connecticut Children's lasting about eight hours. During the visit participants will have hourly blood draws for laboratory lactate and serum glucose alongside finger‑stick measurements using the Lactate Plus meter and the Accu‑Chek glucometer. The trial compares home device readings directly to the corresponding lab values to quantify accuracy and agreement. No investigational treatments are administered; the procedure is limited to paired blood sampling and point-of-care testing.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Patients with diagnosed/confirmed (by liver biopsy or genetic testing) Glycogen Storage Disease Type Ia/Ib (ICD 10 code: E74.01) or XI (74.09).
2. For pediatric participants: Ability of child's parent/legal guardian to understand and the willingness to sign a written informed consent document
3. For adolescents: assent to participate
4. For adults: Ability to understand and the willingness to sign a written informed consent

Exclusion Criteria:

1. Patients with Glycogen storage disease unspecified
2. Patients not meeting inclusion criteria
3. Patients unable to provide consent
4. Patients who decline to be in the study

Where it's running

• Connecticut Children's
  Hartford, Connecticut, United States Recruiting

Study contacts

• Principal investigator: Malaya Mount, MS, RD, CDN — Connecticut Children's
• Study coordinator: Malaya Mount, MS, RD, CDN
• Email: mmount@connecticutchildrens.org
• Phone: 860-837-6700

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Raw cornstarch and glucose readings in adults with glycogen storage disease type I

  This study tests whether eating raw cornstarch with meals changes blood sugar after meals in adults with GSD I using continuous glucose monitoring.

  Recruiting Federico II University · Naples, Napoli · NCT07645898

• Dietary strategies for managing Glycogen Storage Disease Type I

  This study tests if allowing adults with Glycogen Storage Disease Type I to eat more foods with fructose and galactose can improve their quality of life without causing health problems.

  Recruiting Insel Gruppe AG, University Hospital Bern · Bern and 1 other locations · NCT06852612

• Evaluating the accuracy of home lactate meters in patients with Glycogen Storage Disease Type Ia

  This study tests if home lactate meters give accurate readings for people with Glycogen Storage Disease Type Ia by comparing them to lab results.

  Recruiting Connecticut Children's Medical Center · Hartford, Connecticut · NCT06843330

• Evaluating BEAM-301 for treating Glycogen Storage Disease Type Ia

  This study is testing a new treatment called BEAM-301 to see if it is safe and effective for adults with Glycogen Storage Disease Type Ia who have a specific genetic variant.

  Recruiting at 3 sites Phase 1/2 Beam Therapeutics Inc. · Orange, California and 2 other locations · NCT06735755

• Monitoring program for patients with Glycogen Storage Disease Type Ia

  This study is tracking the long-term health and safety of a treatment called DTX401 in people with Glycogen Storage Disease Type Ia to see how it helps them over at least 10 years.

  Recruiting at 17 sites Ultragenyx Pharmaceutical Inc · Orange, California and 18 other locations · NCT06636383

• Glycogen Storage Disease and Brain Function in People Like You

  This study tests whether people with glycogen storage disease perform differently on cognitive tests and show different brain imaging features compared with healthy peers.

  Recruiting Peking Union Medical College Hospital · Beijing, Beijing Municipality · NCT07908212

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.